| Ytd | -20.92% | |
| 1y | -14.60% |
| Open | 64.62 | Prev Close | 64.01 | Low | 64.36 | High | 65.75 | Mkt Cap | 29.50B |
| Vol | 3.50M | Avg Vol | 5.09M | EPS | 4.17 | P/E | 15.55 | Forward P/E | 12.10 |
| Beta | 0.86 | Short Ratio | 3.32 | Inst. Own | 93.91% | Dividend | 0.14 | Div Yield | 0.22 |
| Ex Div Date | 04-02 | Earning | 07-29 | 50-d Avg | 63.87 | 200-d Avg | 74.17 | 1yr Est | 79.22 |
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) t
GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enable
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced Allia™ platform upgrade pathways designed to
RBC Capital analyst Shagun Singh initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a O
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthesia-delivery-syst
Marking the evolution of MIM AI-enabled auto-contouring software, MIM Contour ProtégéAI+ 2.0 introdu
Nuclear medicine is reaching an inflection point as advances in imaging, theranostics and radiopharm